Join us at the EHA2023 Hybrid Congress
The EHA2023 Hybrid Congress marks a special event in the BeiGene calendar. The annual congress of the European Hematology Association presents an excellent opportunity for knowledge sharing and discussing state-of-the-art clinical practice, the latest findings in hematology research, and recent approaches to the diagnosis and treatment of hematologic diseases.
We hope to see you in person in Frankfurt, where you will find us at booth C.111.
Please join the BeiGene-sponsored Satellite Symposium: Improving outcomes for CLL patients – from promising research to current advances in daily practice!
The Satellite Symposium will be held on June 8th, 17.00-18.30 CEST in room Panorama 1, Messe Frankfurt.
Add the Satellite Symposium to your calendar by clicking here!
The Satellite Symposium will provide an overview of current advances in, and future approaches to, the management of patients with treatment-naïve (TN) or relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) using BTK inhibitors (BTKi) and Bcl-2 inhibitors (Bcl-2i). The speakers will reference new treatment guidelines as well as patient and therapy characteristics such as fit vs unfit patients in the era of targeted therapies, continuous vs fixed duration therapy, and monotherapy vs combination therapy. The Satellite Symposium will include patient cases to illustrate how patient and disease characteristics inform treatment selection and sequencing. A summary of novel approaches to targeting BTK and Bcl-2 with the goal of further improving outcomes for CLL patients will also be presented.
BeiGene posters, presentations and webcasts
After the congress, you will find all BeiGene posters, presentations, and the webcast of the Satellite Symposium here.